Gene · 83990
Papers4,271
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 4,271
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| BLM and FANCJ role in the response to G-quadruplex-dependent telomeric replicative stress. | Commun Biol | 2026 | 41495437 | PubTator, text mining | PubMed |
| Skin Cancer Predisposition Genes, Full-Body Skin Examinations, Familial Disclosure, and Genetic Testing Among High-Risk Individuals. | Int J Dermatol | 2026 | 41373161 | PubTator, text mining | PubMed |
| Salpingectomy in individuals at high risk for tubo-ovarian cancer: consensus and precaution. | Am J Obstet Gynecol | 2026 | 41183726 | PubTator, text mining | PubMed |
| Frequency and clinical features of germline pathogenic variants in sarcoma: a case-control study. | J Natl Cancer Inst | 2026 | 41092038 | PubTator, text mining | PubMed |
| Predictive genomic medicine enlarges the spectrum of predisposing mutations for head and neck cancers via a panel of 56 genes selected for human neoplasia in Southern Italy: a pilot study. | Clin Chem Lab Med | 2026 | 40965863 | PubTator, text mining | PubMed |
| Germline pathogenic variants detected by GenMineTOP: insight from a nationwide tumor/normal paired comprehensive genomic profiling test, in Japan. | J Hum Genet | 2026 | 40926019 | PubTator, text mining | PubMed |
| Oncologic outcomes of incidental serous tubal intraepithelial carcinoma and associated high-grade serous carcinoma in high-risk patients undergoing risk-reducing surgery. | Int J Gynecol Cancer | 2026 | 39496390 | PubTator, text mining | PubMed |
| Clinical and Prognostic Relevance of BRIP1 Expression in Colorectal Cancer: Evidence from TCGA and Korean Cohorts. | Medicina (Kaunas) | 2025 | 41597333 | PubTator, text mining | PubMed |
| Clinical and genetic spectrum of Fanconi anemia in Australia and New Zealand. | Genet Med Open | 2025 | 41542348 | PubTator, text mining | PubMed |
| Long-Term Survival With Olaparib Maintenance Therapy in Metastatic Pancreatic Carcinoma of a Patient Harboring Germline BRIP1 and ATM Mutations. | Case Rep Oncol Med | 2025 | 41473825 | PubTator, text mining | PubMed |
| Integrative sWGS: A New Paradigm for HRD Detection in Ovarian Cancer. | Int J Mol Sci | 2025 | 41465396 | PubTator, text mining | PubMed |
| Complex Relationships Between Homologous Recombination Deficiency (HRD) Score and Mutational Status of Homologous Recombination Repair (HRR) Genes in Prostate Carcinomas. | Int J Mol Sci | 2025 | 41465280 | PubTator, text mining | PubMed |
| Auranofin attenuates TOPBP1-mediated ATR replication stress response and improves chemotherapeutic response in breast tumor models. | J Clin Invest | 2025 | 41392982 | PubTator, text mining | PubMed |
| Skin cancer risk in hereditary mixed cancer syndromes. | Hered Cancer Clin Pract | 2025 | 41331641 | PubTator, text mining | PubMed |
| Pediatric Oncology Patients With Germline Pathogenic Variants in Adult-Onset Cancer Predisposition Genes. | JCO Precis Oncol | 2025 | 41325557 | PubTator, text mining | PubMed |
| Synergistic inhibition of CHK1 and MUS81 to combat replication stress resistance in high-risk neuroblastoma. | Sci Rep | 2025 | 41310217 | PubTator, text mining | PubMed |
| Novel Therapeutic Strategy for Renal Cell Carcinoma: Niclosamide Enhances Sunitinib Efficacy via DNA Repair and Cell Cycle Pathways. | Int J Mol Sci | 2025 | 41303409 | PubTator, text mining | PubMed |
| A Plot Twist: When RNA Yields Unexpected Findings in Paired DNA-RNA Germline Genetic Testing. | Genes (Basel) | 2025 | 41300834 | PubTator, text mining | PubMed |
| Recontact and follow-up for individuals with germline pathogenic variants in hereditary breast and ovarian cancer susceptibility genes: a UK Cancer Genetics Group consensus meeting. | J Med Genet | 2025 | 41159931 | PubTator, text mining | PubMed |
| Management of individuals with heterozygous germline pathogenic variants in RAD51C, RAD51D, and BRIP1: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG). | Genet Med | 2025 | 41070818 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/83990/papers?page=5